Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard

    Project: Clinical Trial

    Project Details

    Description

    The investigators study the behavioral consequences of Pre-exposure Prophylaxis or PrEP on sexual health behaviors, sexual health outcomes, and partner selection preferences. The study collects observational, self-reported data on PrEP status, PrEP taking-history, PrEP adherence over the last 30 days, STD diagnosis history dating back to January 2015 up to December 2019, sexual health behaviors (e.g., positioning, number of lifetime/recent partners, condom adherence etc.), and various demographic characteristics. The survey finishes with a conjoint experiment which asks respondents to select between two potential partners, and follow-up question about each profiles. Potential partners' characteristics include recreational drug use and condom adherence. Recruitment is conducted via running an ad on Facebook in New York, London, Toronto and Sydney for comparative purposes, as these metro areas have varying levels of PrEP use and accessibility.
    StatusFinished
    Effective start/end date20/01/2015/03/20

    Keywords

    • Gram-Negative Bacterial Infections
    • Bacterial Infections
    • Bacterial Infections and Mycoses
    • Infections
    • Sexually Transmitted Diseases, Bacterial
    • Communicable Diseases
    • Genital Diseases
    • Urogenital Diseases
    • Disease Attributes
    • Pathologic Processes
    • Neisseriaceae Infections
    • Treponemal Infections
    • Spirochaetales Infections
    • Sexually Transmitted Diseases
    • Gonorrhea
    • Syphilis

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.